DUPILUMAB SIGNIFICANTLY IMPROVES CLINICAL EFFICACY IN PEDIATRIC ATOPIC DERMATITIS PATIENTS <12 YEARS OF AGE

被引:0
|
作者
Katelaris, Constance [1 ,2 ]
Baselga, Eulalia [3 ]
Ramien, Michele [4 ,5 ]
Marcoux, Danielle [6 ,7 ]
de Graaf, Marlies [8 ]
Irvine, Alan [9 ]
Carvalho, Vania Oliveira [10 ]
Ardusso, Ledit R. F. [11 ]
Toledo-Bahena, Mirna [12 ]
Gupta, Rajan [13 ]
Tong, Thu [14 ]
Zhang, Annie [13 ]
机构
[1] Campbelltown Hosp, Campbelltown, Australia
[2] Western Sydney Univ, Sydney, Australia
[3] Hosp St Joan Deu, Barcelona, Spain
[4] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada
[5] Univ Calgary, Calgary, AB, Canada
[6] Univ Montreal, Montreal, PQ, Canada
[7] CHU St Justine Univ Hosp Ctr, Montreal, PQ, Canada
[8] Univ Med Ctr Utrecht, Utrecht, Netherlands
[9] Trinity Coll Dublin, Dublin, Ireland
[10] Univ Fed Parana, Hosp Clin, Curitiba, Brazil
[11] Natl Univ Rosario, Sch Med, Rosario, Argentina
[12] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, Mexico
[13] Sanofi, Cambridge, MA USA
[14] Regeneron Pharmaceut Inc, Tarrytown, NY USA
关键词
D O I
10.1111/imj.81_16230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P82
引用
收藏
页码:29 / 29
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of dupilumab in children aged ≥6 months to <6 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sidbury, Robert
    Lockshin, Benjamin
    Xiao, Jing
    O'Malley, John T.
    Bansal, Ashish
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 561 - 561
  • [22] Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis
    Paller, A. S.
    Simpson, E. L.
    Siegfried, E. C.
    Cork, M. J.
    Wollenberg, A.
    Arkwright, P. D.
    Soong, W.
    Gonzalez, M. E.
    Schneider, L. C.
    Sidbury, R.
    Lockshin, B.
    Wang, Z.
    Mannent, L. P.
    Amin, N.
    Sun, Y.
    Laws, E.
    Akinlade, B.
    Kosloski, M. P.
    Dubost-Brama, A.
    O'Malley, J. T.
    Bansal, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E173 - E173
  • [23] Dupilumab Improves Clinical Scores in Pediatric Patients Aged 2 to <18 Years with Uncontrolled Atopic Dermatitis: A Single-Center, Real-World Study
    Wang, Yifei
    Shen, Chen
    Liu, Danping
    Yang, Liu
    Huang, Changzheng
    Tao, Juan
    DERMATOLOGIC THERAPY, 2023, 2023
  • [24] LABORATORY SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS AGED ≥6-&lt;12 YEARS WITH SEVERE ATOPIC DERMATITIS: RESULTS FROM A PHASE 3 TRIAL (LIBERTY AD PEDS)
    Wollenberg, Andreas
    Thaci, Diamant
    Cork, Michael J.
    Arkwright, Peter D.
    Gooderham, Melinda
    Sun, Xian
    O'Malley, John T.
    Khokhar, Faisal A.
    Bansal, Ashish
    Shumel, Brad
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 59 - 59
  • [25] Dupilumab Was Well Tolerated and Significantly Improved Atopic Dermatitis in Children Aged ≥ 6 to &lt; 12 Years: Results From the LIBERTY AD PEDS Phase 3 Trial
    Marcoux, Danielle
    Wu, Jashin J.
    Shumel, Brad
    Ohya, Yukihiro
    Zhang, Annie
    Chen, Zhen
    PEDIATRICS, 2021, 147 (03)
  • [26] Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
    Guttman-Yassky, Emma
    Bissonnette, Robert
    Ungar, Benjamin
    Suarez-Farinas, Mayte
    Ardeleanu, Marius
    Esaki, Hitokazu
    Suprun, Maria
    Estrada, Yeriel
    Xu, Hui
    Peng, Xiangyu
    Silverberg, Jonathan I.
    Menter, Alan
    Krueger, James G.
    Zhang, Rick
    Chaudhry, Usman
    Swanson, Brian
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Yancopoulos, George D.
    Hamilton, Jennifer D. D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (01) : 155 - 172
  • [27] Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Berdyshev, Evgeny
    Goleva, Elena
    Bissonnette, Robert
    Ramirez-Gama, Marco
    Taylor, Patricia
    Bologna, Gabriel
    Praestgaard, Amy
    Boguniewicz, Mark
    Harel, Sivan
    Levit, Noah A.
    Rossi, Ana B.
    Zhang, Annie
    Leung, Donald Y. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E98 - E98
  • [28] Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
    McKenzie, Paige L.
    Castelo-Soccio, Leslie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (06) : 1691 - 1694
  • [29] Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
    Ferrari, Marco
    Donadu, Matthew G.
    Biondi, Gabriele
    Saderi, Laura
    Sucato, Federica
    Montesu, Maria A.
    Ruggiu, Paola
    Merella, Paola
    Chessa, Carla
    Sias, Angela
    Carmelita, Gabriella
    Mazzarello, Vittorio
    Sotgiu, Giovanni
    Rosanna, Satta
    DERMATOLOGY RESEARCH AND PRACTICE, 2023, 2023
  • [30] Morphea after initiation of dupilumab in two pediatric atopic dermatitis patients
    Wang, Sonia
    Berry, Corbett T.
    Treat, James R.
    Jen, Melinda
    PEDIATRIC DERMATOLOGY, 2023, 40 (03) : 540 - 543